Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly in the development of kinase inhibitors. Shows potential in medicinal chemistry for targeting cancer-related enzymes due to its ability to bind ATP sites in proteins. Also employed in the design of central nervous system agents, where the piperidine-quinoxaline scaffold contributes to blood-brain barrier penetration. Commonly utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates.